4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-038877
CEO and Chairman of the Board acquired 70,155 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Camaisa Allan CEO and Chairman of the Board | 2024-09-26 | Grant or award | +70,155 | $1.15 | $80,678 | 76,712 | D |
Loading xslF345X05/ownership.xml…